EDIT
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Editas Medicine receives approval to initiate the first-in-human clinical trial of EDIT-401 in patients with hyperlipidemiaOct 8, 2026
- The U.S. Patent Office reaffirmed its prior ruling in favor of the Broad Institute in the CRISPR/Cas9 dispute involving EditasMar 27, 2026
- Editas Medicine reports new in vivo proof of concept data on an undisclosed liver target at the American Society of Gene and Cell Therapy Annual Meeting.May 13, 2025